New in MMWR: Respiratory Syncytial Virus (RSV) Vaccine During Pregnancy

["Morbidity and Mortality Weekly Report \(MMWR\) \(CDC\)" <no-reply@xxxxxxxxxxxxxxxxxxxx>]

MMWR Early Release – Vol. 72, October 6, 2023

October 6, 2023

EARLY RELEASE

Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

Respiratory syncytial virus (RSV) is the leading cause of infant hospitalization in the United States. CDC recommends an RSV vaccine during weeks 32-36 of pregnancy to protect young infants.

CONTINUING EDUCATION

New MMWR and Medscape CE on substance use among people with syphilis during pregnancy.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |